Detalhe da pesquisa
1.
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
Invest New Drugs
; 41(1): 115-121, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633784
2.
Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease.
Invest New Drugs
; 40(1): 182-189, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34415485
3.
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Thorac Cancer
; 11(4): 1005-1014, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32057187
4.
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.
Cancer Manag Res
; 10: 7013-7019, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30588105
5.
Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective study.
Thorac Cancer
; 9(10): 1279-1284, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126051